A Clinical Trial of an Investigational Oral Medicine for Type 2 Diabetics with Cardiovascular Risk.
AMR New Orleans is conducting a Clinical Trial of an Investigational Once-Daily ORAL Medication for Type 2 Diabetics with Cardiovascular Risk.
- Are 18 and Older
- Have either Heart Disease (incl. heart attack, stent, bypass surgery, heart failure, among others), Peripheral Artery Disease, Kidney Disease, or have had a Stroke or TIA AND
- Have an A1C of 7 to 10.5 (Stable Treatment of One to Three Oral Medications for Diabetes) Note: If Taking Metformin, ≥1500 mg/day is required.
- Meet Other Study Requirements (Use of Insulin and/or Some Newer Injectable Diabetic Medications is Prohibited)
Reimbursement is available for time and travel.
Contact AMR New Orleans at 504-821-2273.